SE8700761L - Tillempningar av en polypeptid - Google Patents

Tillempningar av en polypeptid

Info

Publication number
SE8700761L
SE8700761L SE8700761A SE8700761A SE8700761L SE 8700761 L SE8700761 L SE 8700761L SE 8700761 A SE8700761 A SE 8700761A SE 8700761 A SE8700761 A SE 8700761A SE 8700761 L SE8700761 L SE 8700761L
Authority
SE
Sweden
Prior art keywords
arg
ser
asn
thr
ala
Prior art date
Application number
SE8700761A
Other languages
English (en)
Other versions
SE8700761D0 (sv
SE457353B (sv
Inventor
T Bartfai
Original Assignee
Trion Forskning & Utveckling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trion Forskning & Utveckling filed Critical Trion Forskning & Utveckling
Publication of SE8700761D0 publication Critical patent/SE8700761D0/sv
Priority to DE8787850394T priority Critical patent/DE3785664T2/de
Priority to EP87850394A priority patent/EP0279151B1/en
Priority to PT86423A priority patent/PT86423B/pt
Priority to AU10891/88A priority patent/AU616649B2/en
Priority to US07/375,004 priority patent/US5283321A/en
Priority to AT87850394T priority patent/ATE88719T1/de
Priority to PCT/SE1987/000619 priority patent/WO1988004665A1/en
Priority to JP63500766A priority patent/JP2635742B2/ja
Publication of SE8700761L publication Critical patent/SE8700761L/sv
Priority to DK392188A priority patent/DK392188A/da
Priority to NO883697A priority patent/NO883697D0/no
Publication of SE457353B publication Critical patent/SE457353B/sv
Priority to FI892985A priority patent/FI892985A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8700761A 1986-12-22 1987-02-24 Pertussistoxinantigen jaemte immunanalystestsats, vaccinkomposition och intradermal hudtestkomposition med naemnda antigen SE457353B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP63500766A JP2635742B2 (ja) 1986-12-22 1987-12-21 新規ポリペプチド及びその用途
US07/375,004 US5283321A (en) 1986-12-22 1987-12-21 Polypeptide compound which binds to glyco-conjugates and to artificial pertussis toxin antigen
EP87850394A EP0279151B1 (en) 1986-12-22 1987-12-21 Pertussis toxin polypeptide and its uses
PT86423A PT86423B (pt) 1986-12-22 1987-12-21 Processo para a preparacao de um novo polipeptido e suas aplicacoes em imunologia
AU10891/88A AU616649B2 (en) 1986-12-22 1987-12-21 A new pertussis toxin derived polypeptide and applications thereof
DE8787850394T DE3785664T2 (de) 1986-12-22 1987-12-21 Pertussis-toxin-polypeptid und seine applikationen.
AT87850394T ATE88719T1 (de) 1986-12-22 1987-12-21 Pertussis-toxin-polypeptid und seine applikationen.
PCT/SE1987/000619 WO1988004665A1 (en) 1986-12-22 1987-12-21 A new pertussis toxin derived polypeptide and applications thereof
DK392188A DK392188A (da) 1986-12-22 1988-07-12 Et hidtil ukendt polypeptid, der er fremstilliet udfra en pertussis-toksin og anvendelser deraf
NO883697A NO883697D0 (no) 1986-12-22 1988-08-18 Nytt pertussis toxin-avledet polypeptid og anvendelse derav.
FI892985A FI892985A0 (fi) 1986-12-22 1989-06-19 Ny polypeptid och anvaendning daerav.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605513A SE468716B (sv) 1986-12-22 1986-12-22 Ny peptid och immunologiskt aktiva foereningar

Publications (3)

Publication Number Publication Date
SE8700761D0 SE8700761D0 (sv) 1987-02-24
SE8700761L true SE8700761L (sv) 1988-06-23
SE457353B SE457353B (sv) 1988-12-19

Family

ID=20366719

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8605513A SE468716B (sv) 1986-12-22 1986-12-22 Ny peptid och immunologiskt aktiva foereningar
SE8700761A SE457353B (sv) 1986-12-22 1987-02-24 Pertussistoxinantigen jaemte immunanalystestsats, vaccinkomposition och intradermal hudtestkomposition med naemnda antigen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8605513A SE468716B (sv) 1986-12-22 1986-12-22 Ny peptid och immunologiskt aktiva foereningar

Country Status (2)

Country Link
IE (1) IE873470L (sv)
SE (2) SE468716B (sv)

Also Published As

Publication number Publication date
IE873470L (en) 1988-06-22
SE8700761D0 (sv) 1987-02-24
SE8605513D0 (sv) 1986-12-22
SE468716B (sv) 1993-03-08
SE457353B (sv) 1988-12-19
SE8605513L (sv) 1988-06-23

Similar Documents

Publication Publication Date Title
DE68905387D1 (de) Aminosaeure-nahrungsmittelzusammensetzungen.
DK532184D0 (da) Antigene aminosyresekvenser
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
NO892407L (no) Aminosyrederivater.
FI102379B1 (sv) Uretanskyddade aminosyra-N-karboxianhydrider
SE8800169D0 (sv) Novel peptide derivatives, their production and use
NO901399L (no) Aminosyrederivater.
IT8622434A0 (it) Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
DK565987A (da) Substituerede aminosyrer
NO901033D0 (no) Aminosyrederivater.
NO903832D0 (no) Aminosyrederivater.
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
MY106287A (en) Acid addition salts of amidated taurine or glycine, their preparation and use
EP0330878A3 (en) Anti-ras protein-antibodies
DE3787657D1 (de) Aminosäure-Derivate.
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
IT8921613A0 (it) Metodo di purificazione di composti a struttura peptidica o pseudo peptidica a basso peso molecolare.
NO901533L (no) Aminosyrederivater.
DE68920896D1 (de) N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung.
NO890635D0 (no) Reninhemmende aminosyrederivater.
SE8700761L (sv) Tillempningar av en polypeptid
MC2264A1 (fr) Derives d'aminoacides
DE3765784D1 (de) Zusammensetzung von aminosaeuren.
NO894880D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DE69018816D1 (de) Aminosäurederivate.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8700761-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8700761-3

Format of ref document f/p: F